IPOs: Still the Exit Strategy of Choice?

By Business Review Editor

Pharma Deals Review: Vol 2006 Issue 72 (Table of Contents)

Published: 6 Jun-2006

DOI: 10.3833/pdr.v2006.i72.507     ISSN: 1756-7874

Section: General

Fulltext:

Abstract

Launching an IPO is a huge and costly commitment in terms of both time and money...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details